X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share (XFOR)

Q: What does CUSIP 98420X103 represent in this 13F holders report?

CUSIP 98420X103 is the security identifier for XFOR - X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held XFOR - X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share in Q2 2023?

96 institutional investors reported XFOR - X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share for Q2 2023. Use the holders table for investor-level position and value details.

CUSIP: 98420X103

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 7,938,059
Total 13F shares: 112,930,152
Share change: +51,913,156
Total reported value: $219,074,939
Put/Call ratio: 7.1%
Price per share: $1.94
Number of holders: 96
Value change: +$103,525,068
Number of buys: 70
Number of sells: 17

Quarterly Holders Quick Answers

What is CUSIP 98420X103?
CUSIP 98420X103 identifies XFOR - X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 98420X103:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of XFOR - X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Bain Capital Life Sciences Investors, LLC	13F	Company	154%	12,202,510	$10,616,000	—	31 Mar 2023	13F
NEA Management Company, LLC	13F	Company	148%	11,736,793	$10,211,010	—	31 Mar 2023	13F
ORBIMED ADVISORS LLC	13F	Company	73%	5,817,726	$5,061,422	—	31 Mar 2023	13F
PERCEPTIVE ADVISORS LLC	13F	Company	57%	4,545,454	$3,954,545	—	31 Mar 2023	13F
AXA S.A.	13F	Company	55%	4,396,468	$3,824,927	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	55%	4,344,311	$3,779,551	—	31 Mar 2023	13F
Tri Locum Partners LP	13F	Company	49%	3,878,484	$3,374,281	—	31 Mar 2023	13F
Parkman Healthcare Partners LLC	13F	Company	35%	2,797,147	$2,433,518	—	31 Mar 2023	13F
Cormorant Asset Management, LP	13F	Company	21%	1,628,980	$1,417,000	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	14%	1,108,684	$964,555	—	31 Mar 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	14%	1,080,213	$940,000	—	31 Mar 2023	13F
Schonfeld Strategic Advisors LLC	13F	Company	13%	1,037,000	$902,190	—	31 Mar 2023	13F
Lynwood Capital Management Inc.	13F	Company	11%	900,000	$783,000	—	31 Mar 2023	13F
Ghost Tree Capital, LLC	13F	Company	11%	850,000	$740,000	—	31 Mar 2023	13F
SCOGGIN MANAGEMENT LP	13F	Company	6.1%	484,796	$567,025	—	31 Mar 2023	13F
Point72 Asset Management, L.P.	13F	Company	8.2%	650,000	$565,500	—	31 Mar 2023	13F
JPMORGAN CHASE & CO	13F	Company	7.9%	626,047	$545,000	—	31 Mar 2023	13F
Simplify Asset Management Inc.	13F	Company	5%	400,000	$348,000	—	31 Mar 2023	13F
Ikarian Capital, LLC	13F	Company	4.4%	349,133	$303,745	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	4.3%	343,580	$298,914	—	31 Mar 2023	13F
New Leaf Venture Partners, L.L.C.	13F	Company	4.2%	335,000	$291,450	—	31 Mar 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	3.6%	282,547	$245,816	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	2.8%	224,470	$195,289	—	31 Mar 2023	13F
Bank of New York Mellon Corp	13F	Company	2.2%	171,193	$148,938	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	2.1%	170,633	$148,451	—	31 Mar 2023	13F
Derek M. Meisner	3/4/5	Chief Legal Officer	— class O/S missing	145,155	$130,640	—	17 Aug 2022	3/4/5
Virtu Financial LLC	13F	Company	1.4%	113,489	$99,000	—	31 Mar 2023	13F
Diego Cadavid	3/4/5	Chief Medical Officer	— class O/S missing	104,107	$93,696	—	01 Mar 2022	3/4/5
UBS Group AG	13F	Company	1.3%	100,000	$87,000	—	31 Mar 2023	13F
XTX Topco Ltd	13F	Company	1.2%	96,649	$84,085	—	31 Mar 2023	13F
STIFEL FINANCIAL CORP	13F	Company	1.2%	93,497	$81,344	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	1.1%	83,482	$72,629	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	0.96%	76,205	$66,299	—	31 Mar 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.75%	59,309	$51,599	—	31 Mar 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.53%	42,386	$36,876	—	31 Mar 2023	13F
LANDSCAPE CAPITAL MANAGEMENT, L.L.C.	13F	Company	0.53%	42,252	$36,759	—	31 Mar 2023	13F
CIBC Private Wealth Group LLC	13F	Company	0.52%	41,500	$36,105	—	31 Mar 2023	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.45%	36,078	$31,388	—	31 Mar 2023	13F
Bleichroeder LP	13F	Company	0.45%	35,730	$31,085	—	31 Mar 2023	13F
SIMPLEX TRADING, LLC	13F	Company	0.41%	32,788	$28,000	—	31 Mar 2023	13F
PNC FINANCIAL SERVICES GROUP, INC.	13F	Company	0.38%	30,350	$26,405	—	31 Mar 2023	13F
GROUP ONE TRADING LLC	13F	Company	0.38%	30,308	$26,368	—	31 Mar 2023	13F
Invesco Ltd.	13F	Company	0.38%	29,945	$26,052	—	31 Mar 2023	13F
COMMONWEALTH EQUITY SERVICES, LLC	13F	Company	0.28%	22,500	$19,000	—	31 Mar 2023	13F
JANE STREET GROUP, LLC	13F	Company	0.27%	21,568	$18,764	—	31 Mar 2023	13F
CITADEL ADVISORS LLC	13F	Company	0.23%	17,961	$15,626	—	31 Mar 2023	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.2%	16,044	$13,958	—	31 Mar 2023	13F
LexAurum Advisors, LLC	13F	Company	0.2%	16,000	$13,920	—	31 Mar 2023	13F
MISSION WEALTH MANAGEMENT, LP	13F	Company	0.19%	15,000	$13,050	—	31 Mar 2023	13F
Veritable, L.P.	13F	Company	0.16%	12,637	$10,994	—	31 Mar 2023	13F

Institutional Holders of X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share (XFOR) as of Q2 2023

As of 30 Jun 2023, X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share (XFOR) was held by 96 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 112,930,152 shares. The largest 10 holders included Bain Capital Life Sciences Investors, LLC, NEA Management Company, LLC, BlackRock Inc., VANGUARD GROUP INC, ORBIMED ADVISORS LLC, MILLENNIUM MANAGEMENT LLC, Stonepine Capital Management, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Tri Locum Partners LP, and Parkman Healthcare Partners LLC. This page lists 96 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Q2 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.